However, due to the significant reduction in the expression of CD8+ T lymphocytes and zonula occludens-1 (ZO-1) in the placebo group, the authors suggest that probiotics may play a role in stabilizing the immune function of the mucosa and also prevent intestinal permeability in MASLD patients [56]. Here, TJP1 is linked to metabolic dysfunction-associated steatotic liver disease.